CLDN4 and gastric cancer: In our previous study, immunohistochemistry was used to examine the expression levels of claudin-4 and MMP-2 and -9 in 189 gastric cancer samples, and their correlation with tumor invasion and clinicopathological parameters was analyzed (34).